Viewing StudyNCT04067336

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 1:36 PM
Last Modification Date: 2024-10-26 @ 1:16 PM
Study NCT ID: NCT04067336
Status: RECRUITING
Last Update Posted: 2024-03-15
First Post: 2019-06-25
Brief Title: First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: Kura Oncology Inc
Organization: Kura Oncology Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Mixed Phenotype Acute Leukemia
Advanced Malignant Neoplasm
Acute Myeloid Leukemia
Mixed Lineage Leukemia
Mixed Lineage Acute Leukemia
Acute Leukemia of Ambiguous Lineage
Keywords:
Name View
Acute Leukemia View
AML View
Hematological malignancy View
KMT2A View
NPM1 View
Menin View
MLLr View
Leukemia View